MLTX
MoonLake Immunotherapeutics
11.40$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | – | – | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | – | – | |
| 0.14 | 0.14 | 0.21 | 0.38 | 0.57 | 0.64 | 0.58 | 0.77 | 0.96 | 0.89 | 0.75 | 0.68 | 3.00 | |
| 0.10 | 0.12 | 0.11 | 0.11 | 0.12 | 0.15 | 0.17 | 0.17 | 0.17 | 0.14 | 0.22 | 0.15 | 0.64 | |
| 0.24 | 0.25 | 0.32 | 0.49 | 0.68 | 0.79 | 0.75 | 0.95 | 1.13 | 1.00 | 0.97 | 0.83 | 3.61 | |
| -0.24 | -0.25 | -0.32 | -0.49 | -0.69 | -0.79 | -0.75 | -0.96 | -1.13 | -1.01 | -0.98 | -0.83 | -3.63 | |
| – | 0.07 | 0.06 | 0.00 | – | – | 0.00 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.14 | |
| -0.22 | -0.13 | -0.22 | -0.39 | -0.57 | -0.73 | -0.64 | -0.88 | -1.11 | -0.97 | -0.97 | -0.83 | -3.57 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | |
| -0.18 | -0.12 | -0.22 | -0.39 | -0.56 | -0.72 | -0.63 | -0.87 | -1.10 | -0.97 | -0.98 | -0.84 | -3.57 | |
| -0.22 | -0.13 | -0.22 | -0.39 | -0.57 | -0.71 | -0.63 | -0.84 | -1.05 | -0.93 | -0.93 | -0.79 | -3.39 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.